Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Virologic Activity, Safety, and Pharmacodynamics of Intravenous Peramivir for the Treatment of Experimental Influenza.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2012
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus infections
- Focus Therapeutic Use
- Sponsors BioCryst Pharmaceuticals
- 25 Jul 2011 New trial record